comparemela.com

Latest Breaking News On - Clinical trials rules - Page 10 : comparemela.com

Bharat Biotech s Covaxin Gets Emergency Use Nod for Kids; 10 Things to Know

Bharat Biotech s Covaxin Gets Emergency Use Nod for Kids; 10 Things to Know
thebetterindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thebetterindia.com Daily Mail and Mail on Sunday newspapers.

New delhiRandeep guleriaExpert committeeSerum institute of indiaIndia institute of medical sciencesWorld health organisationBharat biotechSubject expert committeeZydus cadilaDirector all india instituteMedical sciencesGets emergency use for childrenDrugs controller generalWhole virionInactivated coronavirus vaccinePackage insert

Expert panel recommends Covaxin for 2-18 age group

In a major development, the Subject Expert Committee has recommended emergency use of Bharat Biotech's Covaxin for children aged two years and above.

Expert committeeIndia central drug authorityCentral drugs standard control organisationCentral drug authorityBharat biotechSubject expert committeeDrugs controller generalWhole virionProduct characteristicsNew drugsClinical trials rulesCoronavirus vaccineCovid 19

Covid Expert Panel Recommends Bharat Biotech s Covaxin For Children Between 2-18

Covid Expert Panel Recommends Bharat Biotech s Covaxin For Children Between 2-18
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.

Zydus cadilaSerum institute of indiaExpert committeeIndia central drug authorityCentral drugs standard control organisationCentral drug authorityDrugs controller generalBharat biotechSubject expert committeeWhole virionProduct characteristicsNew drugsClinical trials rulesDrug regulatorHyderabad based biologicale limitedSerum institute

Expert Committee recommends Covaxin for children, DGCI nod awaited

The vaccine manufacturer had completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age in mid-September

New delhiExpert committeeA subject expert committeeCentral drugs standard control organisationWorld health organisationSubject expert committeeDrugs controller generalHyderabad based bharat biotechProduct characteristicsNew drugsClinical trials rulesBharat biotechCovaxin for childrenOvaxin approval for childrenCovaxin trials for childrenCovid vaccine for children

Expert panel recommends emergency use approval for Covaxin in 2 to 18 age group

Final approval of Drugs Controller General of India awaited

Zydus cadilaExpert committeeSubject expert committeeDrugs controller generalWhole virionProduct characteristicsNew drugsClinical trials rulesBharat biotechDrug controller general

vimarsana © 2020. All Rights Reserved.